Park Ha Biological Technology (BYAH) Liabilities and Shareholders Equity (2023 - 2026)

Park Ha Biological Technology has reported Liabilities and Shareholders Equity for 4 years, with the latest figure at $7.5 million in Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 27.92% year-over-year to $7.5 million in Q2 2026; TTM through Apr 2026 was $22.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $6.0 million, up 93.06% from the prior year.
• Liabilities and Shareholders Equity was $7.5 million for Q2 2026 at Park Ha Biological Technology, up from $6.0 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $7.5 million in Q2 2026, with the low at $2.3 million in Q4 2023.
• Average Liabilities and Shareholders Equity over 4 years is $4.9 million, with a median of $5.8 million recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity soared 93.06% in 2025, then gained 27.92% in 2026.
• Over 4 years, Liabilities and Shareholders Equity stood at $2.3 million in 2023, then soared by 36.14% to $3.1 million in 2024, then jumped by 93.06% to $6.0 million in 2025, then gained by 25.34% to $7.5 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $7.5 million (Q2 2026), $6.0 million (Q4 2025), and $5.8 million (Q2 2025), per Business Quant data.